On Friday, Shares of Kinder Morgan Inc (NYSE:KMI), lost -1.80% to $29.22.
Kinder Morgan, declared that its board of directors approved an improvement in its quarterly cash dividend to $0.51 ($2.04 annualized) payable on Nov. 13, 2015, to shareholders of record as of the close of business on Nov. 2, 2015. This represents a 16 percent improvement over the third quarter 2014 dividend of $0.44 per share ($1.76 annualized) and is up from $0.49 per share ($1.96 annualized) for the second quarter of 2015. This is KMI’s 15th quarterly dividend raise since it went public in February 2011.
We are happy with KMIs steady third quarter results that cover our 16 percent dividend improvement to $0.51 per share. We remain on track to meet our full-year dividend target of $2.00 per share with substantial excess cash coverage despite continued challenging conditions in the energy sector, said Executive Chairman Richard D. Kinder. While we are largely insulated from commodity price impacts due to our predominately take-or-pay supported cash flows, we are not totally immune.
Kinder Morgan, Inc. operates as an energy infrastructure and energy company in North America. The company operates through Natural Gas Pipelines, CO2, Terminals, Products Pipelines, Kinder Morgan Canada, and Other segments.
Shares of Apollo Education Group Inc (NASDAQ:APOL), inclined 3.27% to $7.42, during its last trading session.
Apollo Education Group, stated financial results for the three months and fiscal year ended August 31, 2015, with fourth quarter revenue of $600.3 million and a $0.09 diluted loss per share from ongoing operations, or $0.17 earnings per share not taking into account special items.
Fourth Quarter 2015 Results of Operations
Apollo Education Group, stated net revenue for the fourth quarter 2015 of $600.3 million, contrast to $696.1 million for the fourth quarter 2014. Fourth quarter 2015 University of Phoenix New Degreed Enrollment was 26,500 and Degreed Enrollment was 190,700, contrast to New Degreed Enrollment of 38,600 and Degreed Enrollment of 233,500 for the preceding year fourth quarter. Operating loss for the fourth quarter 2015 was $5.0 million, contrast to operating income of $43.5 million for the fourth quarter 2014. Loss from ongoing operations attributable to Apollo Education Group for the fourth quarter 2015 was $10.2 million, or $0.09 per share, contrast to income of $33.0 million, or $0.30 per share, for the preceding year fourth quarter.
Not Taking Into Account special items, operating income was $25.7 million for the fourth quarter 2015, contrast to $58.2 million for the fourth quarter 2014, and income from ongoing operations attributable to Apollo Education Group for the fourth quarter 2015 was $18.7 million, or $0.17 per share, contrast to $38.1 million, or $0.34 per share, for the fourth quarter 2014. Adjusted Operating Income was $55.3 million for the fourth quarter 2015 contrast to $94.1 million for the fourth quarter 2014.
Apollo Education Group, Inc. provides private education services in the United States and internationally. The company offers online and on-campus undergraduate, graduate, certificate, and non-degree educational programs and services to working learners. It operates through University of Phoenix, Apollo Global, and Other segments.
Finally, Shares of Relypsa Inc (NASDAQ:RLYP), ended its last trade with 17.35% gain, and closed at $13.80.
Relypsa, declared that on October 15, 2015, the compensation committee of the company’s board of directors granted nine new employees options to purchase an aggregate of 21,500 shares of the company’s common stock with a per share exercise price of $19.50, the closing trading price on the grant date, and 10,750 restricted stock units. The stock options and restricted stock units were granted following the Relypsa, Inc. 2014 Employment Commencement Incentive Plan, which was approved by the company’s board of directors in June 2014 under Rule 5635(c)(4) of the Nasdaq Global Select Market for equity grants to induce new employees to enter into employment with the company.
Relypsa, Inc., a biopharmaceutical company, focuses on the development and commercialization of non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular, and metabolic diseases in the United States.
DISCLAIMER:
This article is published by www.stocksnewswire.com. The content included in this article is just for informational purposes only. Stocksnewswire.com takes sensible consideration to ensure that the data given in this article is up to date and accurate. The news, prices, opinions, research, analysis, and other information published in this article are obtained from sources believed to be reliable.
Neither Stocksnewswire.com nor any of Stocksnewswire.com partners make any representation or guarantee as to the fulfillment or precision of the information contained in this article.
Investors must consult their own additional due diligence with any potential investment or highlighted company before making any decision on behalf of information offered by Stocksnewswire.com.
Information contained in this article may contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long-term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
